E-LIB Suche - Ergebnisse für: Emery, Maurice G.

1

Phase 1, Single‐ and Multiple‐Ascending‐Dose, Food‐Effect, ..:

Amore, Benny M. ; MacDougall, Diane E. ; Hanselman, Jeffrey C..
Clinical Pharmacology in Drug Development. 12 (2023) 10 - p. 1022-1035 , 2023

Link: https://doi.org/10.1002/..

2

Physiologically Based Pharmacokinetic Model Development and..:

Amore, Benny M. ; Patel, Nikunjkumar ; Batheja, Priya...
Pharmaceutics. 15 (2023) 5 - p. 1476 , 2023

Link: https://doi.org/10.3390/..

3

Population pharmacokinetic and pharmacokinetic-pharmacodyna..:

Jadhav, Satyawan B. ; Amore, Benny M. ; Bockbrader, Howard...
Journal of Pharmacokinetics and Pharmacodynamics. 50 (2023) 5 - p. 351-364 , 2023

Link: https://doi.org/10.1007/..

4

Pharmacokinetics of bempedoic acid in patients with renal i..:

Amore, Benny M. ; Sasiela, William J. ; Ries, Daniel K...
Clinical and Translational Science. 15 (2021) 3 - p. 789-798 , 2021

Link: https://doi.org/10.1111/..

5

Pharmacodynamic effect of bempedoic acid and statin combina..:

Jadhav, Satyawan B ; Crass, Ryan L ; Chapel, Sunny...
European Heart Journal - Cardiovascular Pharmacotherapy. 8 (2021) 6 - p. 578-586 , 2021

Link: https://doi.org/10.1093/..

6

Absence of effect of steady state bempedoic acid on cardiac..:

Amore, Benny M. ; Cramer, Clay T. ; MacDougall, Diane E...
Clinical and Translational Science. 14 (2021) 6 - p. 2487-2496 , 2021

Link: https://doi.org/10.1111/..

7

Influence of Renal Function on Evolocumab Exposure, Pharmac..:

Lee, Edward ; Gibbs, John P. ; Emery, Maurice G....
Clinical Pharmacology in Drug Development. 8 (2019) 3 - p. 281-289 , 2019

Link: https://doi.org/10.1002/..

8

Population pharmacokinetics and exposure–response modeling ..:

Kuchimanchi, Mita ; Grover, Anita ; Emery, Maurice G....
Journal of Pharmacokinetics and Pharmacodynamics. 45 (2018) 3 - p. 505-522 , 2018

Link: https://doi.org/10.1007/..

9

Clinical Pharmacokinetics and Pharmacodynamics of Evolocuma..:

Kasichayanula, Sreeneeranj ; Grover, Anita ; Emery, Maurice G....
Clinical Pharmacokinetics. 57 (2018) 7 - p. 769-779 , 2018

Link: https://doi.org/10.1007/..

10

Comparison of LDL-C Reduction Using Different Evolocumab Do..:

Wasserman, Scott M. ; Sabatine, Marc S. ; Koren, Michael J....
Journal of Cardiovascular Pharmacology and Therapeutics. 23 (2018) 5 - p. 423-432 , 2018

Link: https://doi.org/10.1177/..

11

Evaluation of Evolocumab (AMG 145), a Fully Human Anti‐PCSK..:

Gibbs, John P. ; Slatter, J. Greg ; Egbuna, Ogo...
The Journal of Clinical Pharmacology. 57 (2016) 4 - p. 513-523 , 2016

Link: https://doi.org/10.1002/..

12

Impact of Target‐Mediated Elimination on the Dose and Regim..:

Gibbs, John P. ; Doshi, Sameer ; Kuchimanchi, Mita...
The Journal of Clinical Pharmacology. 57 (2016) 5 - p. 616-626 , 2016

Link: https://doi.org/10.1002/..

13

Synthesis and Evaluation of the Metabolites of AMG 221, a C..:

Li, Aiwen ; Yuan, Chester C. ; Chow, David...
ACS Medicinal Chemistry Letters. 2 (2011) 11 - p. 824-827 , 2011

Link: https://doi.org/10.1021/..

14

Population Pharmacokinetic/Pharmacodynamic Model of Subcuta..:

Gibbs, John P. ; Emery, Maurice G. ; McCaffery, Ian...
The Journal of Clinical Pharmacology. 51 (2011) 6 - p. 830-841 , 2011

Link: https://doi.org/10.1177/..

15

Discovery of a Potent, Orally Active 11β-Hydroxysteroid Deh..:

Véniant, Murielle M. ; Hale, Clarence ; Hungate, Randall W....
Journal of Medicinal Chemistry. 53 (2010) 11 - p. 4481-4487 , 2010

Link: https://doi.org/10.1021/..